The Institute for Network Medicine (iNetMed) unites several research disciplines to develop disruptive solutions, transform life sciences and technology and enhance human health. When founded in March of 2018, iNetMed was comprised of 3 centers: PreCSN, ConCISE, and HUMANOID. In 2024, iNetMed added a 4th center, the Agilent Center of Excellence (ACoE) in Cellular Intelligence.
The Agilent Center of Excellence in Cellular Intelligence (ACoE) provides a complete suite of high-end equipment that promises to modernize readouts of cell fate, state, and trait – in vitro and in tissues – thereby erasing pain points in quantitative cell analyses.
The Consortium for Cell-Inspired Systems Engineering (ConCISE) is building a bridge between the life sciences and natural sciences. As the iNetMed’s engineering arm, ConCISE is building virtual human cells to better understand how they degenerate or go rogue, as well as engineer smarter machines that can sense, decide, act, learn, and adapt – the way cells do.
The HUMANOID Center of Research Excellence (CoRE) is the translational arm for iNetMed’s drug discovery pipeline, bringing a new level of personalization into disease modeling and clinical trials, providing the ability to test the efficacy of therapeutics in Phase “0”.
The Precision Computational Systems Network (PreCSN) is radically changing how we sift through big data to find meaningful information. As the computational arm for the iNetMed’s drug discovery pipeline, PreCSN develops novel machine learning algorithms to drive precision drug discovery.